Company: Takeda Pharmaceutical Co. Ltd.
Job title: LBx Strategy Lead, Precision Medicine and Companion Diagnostics
Chair’s Opening Remarks 8:50 am
day: Day Two
Panel Discussion on Equity, Diversity & Inclusion (ED&I): Expediting Liquid Biopsy Development & Validation for Early Screening to Advance Equity in Personalized Treatment 9:30 am
What are the benefits of capturing a diverse and inclusive genetic and molecular characteristic for advancing equity in early screening? When examining research on biomarkers and clinical trials, do you believe there is a significant lack of inclusion in the design and execution of studies, and if so, what measures should be taken to address…Read more
day: Day One